Singh, K., Hotchkiss, K., Foster, M., Railton, C., Blandford, E., Thomas, E., … Khasraw, M. (2023). A SURGICAL WINDOW-OF-OPPORTUNITY CLINICAL TRIAL EVALUATING THE PCSK9 INHIBITOR EVOLOCUMAB IN PATIENTS WITH GLIOMA. In NEURO-ONCOLOGY (Vol. 25).

Singh, Kirit, Kelly Hotchkiss, Matthew Foster, Chelsea Railton, Emily Blandford, Elizabeth Thomas, Elizabeth S. Miller, et al. “A SURGICAL WINDOW-OF-OPPORTUNITY CLINICAL TRIAL EVALUATING THE PCSK9 INHIBITOR EVOLOCUMAB IN PATIENTS WITH GLIOMA.” In NEURO-ONCOLOGY, Vol. 25, 2023.

Singh K, Hotchkiss K, Foster M, Railton C, Blandford E, Thomas E, et al. A SURGICAL WINDOW-OF-OPPORTUNITY CLINICAL TRIAL EVALUATING THE PCSK9 INHIBITOR EVOLOCUMAB IN PATIENTS WITH GLIOMA. In: NEURO-ONCOLOGY. 2023.

Singh, Kirit, et al. “A SURGICAL WINDOW-OF-OPPORTUNITY CLINICAL TRIAL EVALUATING THE PCSK9 INHIBITOR EVOLOCUMAB IN PATIENTS WITH GLIOMA.” NEURO-ONCOLOGY, vol. 25, 2023.

Singh K, Hotchkiss K, Foster M, Railton C, Blandford E, Thomas E, Miller ES, Ashley D, Desjardins A, Friedman H, Johnson MO, Friedman A, Keir S, Herndon J, Sampson J, Li C-Y, Fecci P, Patel A, Khasraw M. A SURGICAL WINDOW-OF-OPPORTUNITY CLINICAL TRIAL EVALUATING THE PCSK9 INHIBITOR EVOLOCUMAB IN PATIENTS WITH GLIOMA. NEURO-ONCOLOGY. 2023.